Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
ClinicalTrials.gov study NCT05626101. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00068432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
ClinicalTrials.gov study NCT02992015. IPD Sharing: NO. Countries: 1. Publications: 0.
PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
ClinicalTrials.gov study NCT00088660. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01693419. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT00906061. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
ClinicalTrials.gov study NCT04940286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
ClinicalTrials.gov study NCT02005419. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
ClinicalTrials.gov study NCT01888302. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT01770795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer
ClinicalTrials.gov study NCT00346281. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer
ClinicalTrials.gov study NCT01051284. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas
ClinicalTrials.gov study NCT00134641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy
ClinicalTrials.gov study NCT03883919. IPD Sharing: YES. Countries: 1. Publications: 0.
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer
ClinicalTrials.gov study NCT00623064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
ClinicalTrials.gov study NCT00004220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05401279. IPD Sharing: NO. Countries: 1. Publications: 0.
Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
ClinicalTrials.gov study NCT02023021. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer
ClinicalTrials.gov study NCT01598584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
ClinicalTrials.gov study NCT04605913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.